vTv Therapeutics Inc. Class A Common Stock (VTVT)
vTv Therapeutics Inc. Class A (VTVT) is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases and diabetes. The company leverages proprietary technologies to pioneer novel treatment options, with an emphasis on improving patient outcomes in chronic and traditionally underserved conditions.
Company News
vTv Therapeutics appointed a Scientific Advisory Board of distinguished clinicians and scientists to provide strategic guidance on cadisegliatin, a potential oral treatment for type 1 diabetes currently in Phase 3 clinical trials.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling  Leading and Lag...
Penny stocks under $1 to watch this week. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
vTv Therapeutics (VTVT) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?